Humanized anti-CD19 antibodies
US8883992B2 · kind B2 · utility
3Cited by
20References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2012 |
| Grant date | Nov 11, 2014 |
| Priority date | — |
| Expiry date | Oct 26, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Isolated nucleic acids encoding anti-CD19 mouse monoclonal antibodies are described herein. Also described are expression vectors, host cells and a method of producing anti-CD19 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.